# COOL RCN: Cooling to Prevent Radiocontrast Nephropathy

> **NCT00306306** · PHASE2,PHASE3 · TERMINATED · sponsor: **Radiant Medical** · enrollment: 400 (estimated)

## Conditions studied

- Renal Failure
- Kidney Failure
- Renal Insufficiency

## Interventions

- **DEVICE:** Reprieve Endovascular Temperature Therapy System

## Key facts

- **NCT ID:** NCT00306306
- **Lead sponsor:** Radiant Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306306, "COOL RCN: Cooling to Prevent Radiocontrast Nephropathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00306306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*